Vivoryon Therapeutics N.V. (LON:0R3M)
London
· Delayed Price · Currency is GBP · Price in EUR 1.456
+0.016 (1.11%)
At close: Jul 9, 2025
Vivoryon Therapeutics Market Cap
Vivoryon Therapeutics has a market cap or net worth of 32.79 million as of July 10, 2025. Its market cap has decreased by -24.76% in one year.
Market Cap
32.79M
Enterprise Value
24.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.46
Market Cap Chart
Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 106.65M to 32.79M, a decrease of -69.26%. That is a compound annual growth rate of -10.43%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.34B |
| GSK plc | 57.21B |
| Haleon | 33.35B |
| Smith & Nephew | 9.63B |
| ConvaTec Group | 5.35B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 1.98B |
| Indivior | 1.41B |